BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32813265)

  • 1. Nose-to-Brain Delivery of Diazepam from an Intranasal Aqua-Triggered In-Situ (ATIS) Gelling Microemulsion: Monitoring Brain Uptake by Microdialysis.
    Bachhav SS; Dighe V; Mali N; Gogtay NJ; Thatte UM; Devarajan PV
    Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):785-799. PubMed ID: 32813265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation.
    Ramreddy S; Janapareddi K
    Drug Dev Ind Pharm; 2019 Jan; 45(1):147-158. PubMed ID: 30230386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting.
    Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
    J Pharm Sci; 2006 Mar; 95(3):570-80. PubMed ID: 16419051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microemulsion based intranasal delivery system for treatment of insomnia.
    Porecha S; shah T; Jogani V; Naik S; Misra A
    Drug Deliv; 2009 Apr; 16(3):128-34. PubMed ID: 19514972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
    J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin.
    Wang S; Chen P; Zhang L; Yang C; Zhai G
    J Drug Target; 2012 Dec; 20(10):831-40. PubMed ID: 22934854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
    Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
    Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam.
    Li L; Nandi I; Kim KH
    Int J Pharm; 2002 Apr; 237(1-2):77-85. PubMed ID: 11955806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study.
    Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
    Drug Deliv; 2016; 23(1):207-13. PubMed ID: 24825492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
    Galgatte UC; Kumbhar AB; Chaudhari PD
    Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL; Bharkad GP; Devarajan PV
    Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
    Kaur P; Kim K
    Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Nasal Temperature and pH Dual-Responsive In Situ Gel Delivery System Based on Microemulsion of Huperzine A: Formulation, Evaluation, and In Vivo Pharmacokinetic Study.
    Chen Y; Cheng G; Hu R; Chen S; Lu W; Gao S; Xia H; Wang B; Sun C; Nie X; Shen Q; Fang W
    AAPS PharmSciTech; 2019 Sep; 20(7):301. PubMed ID: 31485857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting.
    Jose S; Ansa CR; Cinu TA; Chacko AJ; Aleykutty NA; Ferreira SV; Souto EB
    Int J Pharm; 2013 Jan; 441(1-2):516-26. PubMed ID: 23147411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers.
    Agarwal SK; Kriel RL; Brundage RC; Ivaturi VD; Cloyd JC
    Epilepsy Res; 2013 Aug; 105(3):362-7. PubMed ID: 23561287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
    Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
    Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
    Shah B; Khunt D; Misra M; Padh H
    Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.
    Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
    AAPS PharmSciTech; 2006 Jan; 7(1):E8. PubMed ID: 16584167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.